CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, announced
today that President and Chief Executive Officer, Hany Massarany, will
attend the 2017 Canaccord Genuity Growth Conference in Boston. Mr.
Massarany will participate in an analyst-led fireside chat on Wednesday,
August 9 at 8:00 AM Eastern Time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care, improve
key quality metrics, and reduce the total cost-of-care. Utilizing
GenMark's proprietary eSensor® detection technology, GenMark's eSensor
XT-8® and ePlex® systems are designed to support a broad range of
molecular diagnostic tests with compact, easy-to-use workstations and
self-contained, disposable test cartridges. GenMark's ePlex: The True
Sample-to-Answer Solution™ is designed to optimize laboratory
efficiency and address a broad range of infectious disease testing
needs, including respiratory, bloodstream, and gastrointestinal
infections. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170731006030/en/
GenMark Diagnostics, Inc.
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media